U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Endometrial Mucinous Adenocarcinoma, Intestinal-Type

MedGen UID:
1792890
•Concept ID:
C5556449
•
Neoplastic Process

Definition

A rare mucinous adenocarcinoma arising from intestinal metaplasia of the endometrium. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVEndometrial Mucinous Adenocarcinoma, Intestinal-Type

Recent clinical studies

Etiology

Mucinous Proliferations of the Uterine Corpus: Comprehensive Appraisal of an Evolving Spectrum of Neoplasms.
Fadare O
Adv Anat Pathol 2022 Sep 1;29(5):275-296. Epub 2022 May 3 doi: 10.1097/PAP.0000000000000348. PMID: 35499137
From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
Young RH
Adv Anat Pathol 2007 May;14(3):149-77. doi: 10.1097/PAP.0b013e3180504abf. PMID: 17452813

Diagnosis

Primary endometrial gastric (gastro-intestinal)-type carcinoma: A practical approach.
Dridi M, Peoc'h M, Karpathiou G
Pathol Res Pract 2023 Jan;241:154271. Epub 2022 Dec 6 doi: 10.1016/j.prp.2022.154271. PMID: 36502736
Appendiceal Endometriosis with Intestinal Metaplasia Mimicking Appendiceal Mucinous Neoplasm - A Case Report and a Concise Review for the Practicing Pathologist.
Chitul M, Chivu M, Chitul A, Popa I, Becheanu G, Cristian D, Grama F
Int J Surg Pathol 2023 Jun;31(4):435-441. Epub 2022 Jul 14 doi: 10.1177/10668969221105621. PMID: 35833324
Mucinous Proliferations of the Uterine Corpus: Comprehensive Appraisal of an Evolving Spectrum of Neoplasms.
Fadare O
Adv Anat Pathol 2022 Sep 1;29(5):275-296. Epub 2022 May 3 doi: 10.1097/PAP.0000000000000348. PMID: 35499137
Intestinal-type mucinous ovarian carcinoma arising from a seromucinous precursor lesion.
Santoro A, D'Alessandris N, Travaglino A, Arciuolo D, Inzani F, Angelico G, Scaglione G, Valente M, Raffone A, Zannoni GF
Eur Rev Med Pharmacol Sci 2022 Feb;26(4):1263-1267. doi: 10.26355/eurrev_202202_28119. PMID: 35253183
Trefoil factor family 2 protein: a potential immunohistochemical marker for aiding diagnosis of lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix.
Asaka S, Nakajima T, Momose M, Miyamoto T, Uehara T, Ota H
Virchows Arch 2019 Jan;474(1):79-86. Epub 2018 Oct 15 doi: 10.1007/s00428-018-2469-z. PMID: 30324235

Prognosis

Trefoil factor family 2 protein: a potential immunohistochemical marker for aiding diagnosis of lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix.
Asaka S, Nakajima T, Momose M, Miyamoto T, Uehara T, Ota H
Virchows Arch 2019 Jan;474(1):79-86. Epub 2018 Oct 15 doi: 10.1007/s00428-018-2469-z. PMID: 30324235
Endometrial metaplasias and reactive changes: a spectrum of altered differentiation.
Nicolae A, Preda O, Nogales FF
J Clin Pathol 2011 Feb;64(2):97-106. Epub 2010 Dec 1 doi: 10.1136/jcp.2010.085555. PMID: 21126963

Clinical prediction guides

Trefoil factor family 2 protein: a potential immunohistochemical marker for aiding diagnosis of lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix.
Asaka S, Nakajima T, Momose M, Miyamoto T, Uehara T, Ota H
Virchows Arch 2019 Jan;474(1):79-86. Epub 2018 Oct 15 doi: 10.1007/s00428-018-2469-z. PMID: 30324235

Supplemental Content

Table of contents

    Practice guidelines

    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...